alpha 2C Adrenergic Receptor (ADRA2C) Mouse Monoclonal Antibody [Clone ID: N330A/51]

CAT#: 75-300

alpha 2C Adrenergic Receptor (ADRA2C) mouse monoclonal antibody, clone N330A/51

Product Images

Transfected cell immunoblot: extracts of COS cells transiently transfected with HA-tagged Alpha-2C and Alpha-2A adrenergic receptor or untagged Kv2.1 plasmid and probed with N330A/51 TC supe.

Specifications

Product Data

• Clone Name: N330A/51
• Applications: IF, WB
• Recommended Dilution: Immunoblot (IB)
  Immunocytochemistry (ICC)
• Reactivities: Human, Mouse
• Host: Mouse
• Isotype: IgG2a
• Clonality: Monoclonal
• Immunogen: Synthetic peptide amino acids 442-462 (QDFRRSFKHILFRRRRRGFRQ, cytoplasmic C-terminus) of human Alpha-2C adrenergic receptor (also known as Alpha-2 adrenergic receptor subtype C4, Alpha-2C adrenoreceptor, Alpha-2CAR, ADRA2C, ADRA2L2 and ADRARL2, accession number P18825).
  Mouse: 100% identity (21/21 amino acids identical)
  Rat: 100% identity (21/21 amino acids identical)
  >70% identity with Alpha-2B adrenergic receptor
• Specificity: Does not cross-react with other adrenergic receptors (based on KO validation results)
• Formulation: State: Purified
• Conjugation: Unconjugated
• Gene Name: adrenoceptor alpha 2C
• Database Link:
  Entrez Gene 152 Human
  UniProt ID P18825
• Synonyms: ADRA2L2, ADRA2RL2, Alpha-2C adrenoreceptor, Alpha-2C adrenoceptor
• Note: USERS will cite the UC Davis/NIH NeuroMab Facility in any publication(s) describing the research utilizing the MATERIALS. The suggested acknowledgment statement is as follows:
  "The monoclonal antibody _ was developed by and/or obtained from the UC Davis/NIH NeuroMab Facility, supported by NIH grant U24NS050606 and maintained by the Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis, CA 95616."
  Also, please include the complete clone number (e.g., N52A/42) and the Antibody Registry identification number (e.g., RRID:AB_2120479) to avoid ambiguity.
  View Research License Agreement